Citius Pharmaceuticals (Warrant)

YTD

ALL

Why Robinhood?

You can watch CTXRW and buy or sell other stocks, ETFs, and their options commission-free!

About CTXRW

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite.

CEO

Leonard L. Mazur, MBA

CEOLeonard L. Mazur, MBA

Employees

—

Employees—

Headquarters

Cranford, New Jersey

HeadquartersCranford, New Jersey

Founded

2007

Founded2007

Employees

—

Employees—

CTXRW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

CTXRW News

TipRanks 4d

Citius Pharmaceuticals Announces LYMPHIR Commercialization Plans

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 7d

Citius Pharmaceuticals announces $6M registered direct offering priced ATM

Citius Pharmaceuticals (CTXR) announced that it has entered into definitive agreement for the purchase of an aggregate of 3,973,510 shares of its common stock a...